Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 79Observational 2

Sponsor

Cancer Type

Lymphoid 2Myeloid 1

Conditions

Multiple Myeloma 7Recurrence 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Mantle-Cell 3Lymphoma, Follicular 2Lymphoma 2Tumor Lysis Syndrome 1Thromboembolism 1Teratogenesis 1Sleepiness 1Seizures 1Renal Insufficiency 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Peripheral Nervous System Diseases 1Neoplasms, Second Primary 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Lung Diseases, Interstitial 1Infections 1Hypothyroidism 1Hypotension, Orthostatic 1Hypersensitivity 1Hemorrhage 1Heart Failure 1Fatigue 1Dizziness 1Digestive System Diseases 1Coronary Artery Disease 1Confusion 1

Interventions

Rituximab 6Polymerase Chain Reaction 6Amplified Fragment Length Polymorphism Analysis 6Gene Expression Profiling 5obinutuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Microarray Analysis 4Immunohistochemistry 4Flow Cytometry 4Therapeutics 3Immunoenzyme Techniques 3Drug Therapy 3tisagenlecleucel 2duvelisib 2Prednisone 2Lenalidomide 2Influenza Vaccines 2Immunologic Techniques 2Echocardiography 2Blood Specimen Collection 2zanubrutinib 1tazemetostat 1relmacabtagene autoleucel 1pomalidomide 1ibritumomab tiuxetan 1deucravacitinib 1Watchful Waiting 1Waiting Lists 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Lymphoma, Follicular × Lenalidomide × Clear all
NCT04036448 2025-03-11

RevlimidPMS

Celgene

Completed
28 enrolled
LymphoidMyeloid

Lymphoma, Follicular, Myelodysplastic Syndromes, Recurrence, Lymphoma, Mantle-Cell

NCT05899621 2023-06-12

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Ruijin Hospital

Recruiting
332 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡